Advertisement
MEDXF.OB Novinky na Forexe
Medexus Pharma Resubmits Treosulfan NDA To FDA
Medexus Pharmaceuticals (MDP.TO, MEDXF.OB) and its strategic partner medac announced Monday that medac has resubmitted its New Drug Application (NDA) for treosulfan with the U.S. Food and Drug Administration (FDA).
RTTNews
|
Pred 1055 dňami
